Workflow
Disc Medicine(IRON)
icon
Search documents
Disc Medicine(IRON) - 2023 Q1 - Quarterly Report
2023-05-15 11:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission File Number: 001-39438 Disc Medicine, Inc. (Exact name of registrant as specified in its charter) (State or other jur ...
Disc Medicine(IRON) - 2022 Q4 - Annual Report
2023-03-31 11:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________ Commission file number: 001-39438 Disc Medicine, Inc. (Exact name of registrant as specified in its charter) Delaware 82-3220679 (State or ...
Gemini Therapeutics (GMTX) Investor Presentation - Slideshow
2021-11-23 12:58
© Gemini Therapeutics, 2021 © Gemini Therapeutics, 2021 November 2021 Disclaimer 2 Forward-Looking Statements Certain statements in this presentation and the information incorporated herein by reference may constitute "forward-looking statements" for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future, including those relating to t ...
Gemini Therapeutics (GMTX) Investor Presentation - Slideshow
2021-08-23 17:35
© Gemini Therapeutics, 2021 © Gemini Therapeutics, 2021 August 2021 Disclaimer 2 Forward-Looking Statements Certain statements in this press release and the information incorporated herein by reference may constitute "forward-looking statements" for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future, including those relating to th ...